EUVIMEDEUVIMED entdecken
Crossref

Association of polymorphic markers Arg753Gln in the TLR2 Gene, T-1237C and G2848A in the TLR9 Gene with the risk of developing primary adrenal insufficiency in individuals living in the Moscow Region of the Russian Federation

Ekaterina A. Meremianina, Ekaterina A. Troshina, Marina Yu. Yukina, Nurana F. Nuralieva, Natalia O. Kalyuzhnaya, Natalya D. Abramova, Nadezhda D. Rasskazova, Ilia N. Diakov, Oksana A. Svitich

Annals of the Russian academy of medical sciences · 19.06.2026 · 81 (2) · 139-145

DOI: 10.15690/vramn18170 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of the Russian academy of medical sciences, online erschienen am 19.06.2026. Verfasst von Ekaterina A. Meremianina und 8 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Primary adrenal insufficiency (PAI) is an endocrine disorder caused by the gradual destruction of all three layers of the adrenal cortex and characterized by insufficient secretion of cortisol and aldosterone. This condition significantly reduces patients’ quality of life, making its timely diagnosis crucial. Autoimmune disorders are the etiological factor in approximately 80% of PAI cases, making the search for predictive markers in innate immune genes one of the most promising areas for predicting the odds of developing PAI. Aims — to study the associations between single nucleotide polymorphisms in the TLR2 and TLR9 genes and the development of PAI.

Methods

The study included 222 individuals: 72 patients with PAI and 150 controls. For the study, DNA was isolated from venous blood and subsequently analyzed using real-time PCR with fluorescently labeled probes. Statistical analysis of the results was performed using Fisher’s exact test (Fi), the χ2 test, the χ2 test with Yates’ correction, calculation of the odds ratio and 95% confidence interval.

Results

The study revealed that the A allele (p 0.001) and the heterozygous genotype (p 0.001) of the rs5743708 polymorphism in the TLR2 gene were associated with the risk of developing PAI. Conversely, the homozygous genotype GG (p 0.001) reduced the odds of the pathology development by 11-fold. Analysis of the rs352140 single nucleotide polymorphism in the TLR9 gene also demonstrated an association between the A allele (p = 0.030) and the homozygous AA genotype (p = 0.0171) with the odds of developing PAI.

Conclusions

Based on the data obtained in this and our previous study, a scheme was proposed that includes four polymorphic markers to predict the odds of developing 1-HH.

Zitieren

APA

Meremianina, E. A., Troshina, E. A., Yukina, M. Y., Nuralieva, N. F., Kalyuzhnaya, N. O., Abramova, N. D., Rasskazova, N. D., Diakov, I. N., & Svitich, O. A. (2026). Association of polymorphic markers Arg753Gln in the TLR2 Gene, T-1237C and G2848A in the TLR9 Gene with the risk of developing primary adrenal insufficiency in individuals living in the Moscow Region of the Russian Federation. Annals of the Russian academy of medical sciences, 81(2), 139-145. https://doi.org/10.15690/vramn18170

Vancouver

Meremianina EA, Troshina EA, Yukina MY, Nuralieva NF, Kalyuzhnaya NO, Abramova ND, et al. Association of polymorphic markers Arg753Gln in the TLR2 Gene, T-1237C and G2848A in the TLR9 Gene with the risk of developing primary adrenal insufficiency in individuals living in the Moscow Region of the Russian Federation. Annals of the Russian academy of medical sciences. 2026;81(2):139-145. doi:10.15690/vramn18170

BibTeX
@article{Meremianina2026,
  author = {Meremianina, Ekaterina A. and Troshina, Ekaterina A. and Yukina, Marina Yu. and Nuralieva, Nurana F. and Kalyuzhnaya, Natalia O. and Abramova, Natalya D. and Rasskazova, Nadezhda D. and Diakov, Ilia N. and Svitich, Oksana A.},
  title = {Association of polymorphic markers Arg753Gln in the TLR2 Gene, T-1237C and G2848A in the TLR9 Gene with the risk of developing primary adrenal insufficiency in individuals living in the Moscow Region of the Russian Federation},
  journal = {Annals of the Russian academy of medical sciences},
  year = {2026},
  volume = {81},
  number = {2},
  pages = {139--145},
  doi = {10.15690/vramn18170}
}
Kostenlos starten →